124 related articles for article (PubMed ID: 8453506)
41. SC-19220, antagonist of prostaglandin E2 receptor EP1, inhibits osteoclastogenesis by RANKL.
Tsujisawa T; Inoue H; Nishihara T
J Bone Miner Res; 2005 Jan; 20(1):15-22. PubMed ID: 15619665
[TBL] [Abstract][Full Text] [Related]
42. Partial loss of anabolic effect of prostaglandin E2 on bone after its withdrawal in rats.
Ke HZ; Li XJ; Jee WS
Bone; 1991; 12(3):173-83. PubMed ID: 1910959
[TBL] [Abstract][Full Text] [Related]
43. Additive effect of treadmill exercise and 17 beta-estradiol replacement on prevention of tibial bone loss in adult ovariectomized rat.
Yeh JK; Liu CC; Aloia JF
J Bone Miner Res; 1993 Jun; 8(6):677-83. PubMed ID: 8328309
[TBL] [Abstract][Full Text] [Related]
44. Arachidonic acid and prostaglandin E2 influence human osteoblast (MG63) response to titanium surface roughness.
Dean DD; Campbell CM; Gruwell SF; Tindall JW; Chuang HH; Zhong W; Schmitz JP; Sylvia VL
J Oral Implantol; 2008; 34(6):303-12. PubMed ID: 19133484
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of signal transduction mechanisms for the mitogenic effects of prostaglandin E2 in normal human bone cells in vitro.
Baylink TM; Mohan S; Fitzsimmons RJ; Baylink DJ
J Bone Miner Res; 1996 Oct; 11(10):1413-8. PubMed ID: 8889840
[TBL] [Abstract][Full Text] [Related]
46. Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells.
Collins DA; Chambers TJ
J Bone Miner Res; 1992 May; 7(5):555-61. PubMed ID: 1615762
[TBL] [Abstract][Full Text] [Related]
47. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
Katz IA; Jee WS; Joffe II; Stein B; Takizawa M; Jacobs TW; Setterberg R; Lin BY; Tang LY; Ke HZ
J Bone Miner Res; 1992 Oct; 7(10):1191-200. PubMed ID: 1456087
[TBL] [Abstract][Full Text] [Related]
48. Regulation of interleukin-6 production by prostaglandin E2 in fetal rat osteoblasts: role of protein kinase A signaling pathway.
Millet I; McCarthy TL; Vignery A
J Bone Miner Res; 1998 Jul; 13(7):1092-100. PubMed ID: 9661073
[TBL] [Abstract][Full Text] [Related]
49. Restoration of bone mass in the severely osteopenic senescent rat.
Sibonga JD; Zhang M; Ritman EL; Turner RT
J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):B71-8; discussion B79-84. PubMed ID: 10737682
[TBL] [Abstract][Full Text] [Related]
50. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts.
Tanaka H; Tanabe N; Shoji M; Suzuki N; Katono T; Sato S; Motohashi M; Maeno M
Life Sci; 2006 Mar; 78(15):1733-40. PubMed ID: 16266722
[TBL] [Abstract][Full Text] [Related]
51. Bone marrow cells are targets for the anabolic actions of prostaglandin E2 on bone: induction of a transition from nonadherent to adherent osteoblast precursors.
Scutt A; Bertram P
J Bone Miner Res; 1995 Mar; 10(3):474-87. PubMed ID: 7785470
[TBL] [Abstract][Full Text] [Related]
52. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing.
Li M; Ke HZ; Qi H; Healy DR; Li Y; Crawford DT; Paralkar VM; Owen TA; Cameron KO; Lefker BA; Brown TA; Thompson DD
J Bone Miner Res; 2003 Nov; 18(11):2033-42. PubMed ID: 14606517
[TBL] [Abstract][Full Text] [Related]
53. Systemic prostaglandin E2 increases cancellous bone formation and mass in aging rats and stimulates their bone marrow osteogenic capacity in vivo and in vitro.
Keila S; Kelner A; Weinreb M
J Endocrinol; 2001 Jan; 168(1):131-9. PubMed ID: 11139777
[TBL] [Abstract][Full Text] [Related]
54. ADAMTS-1: A cellular disintegrin and metalloprotease with thrombospondin motifs is a target for parathyroid hormone in bone.
Miles RR; Sluka JP; Halladay DL; Santerre RF; Hale LV; Bloem L; Thirunavukkarasu K; Galvin RJ; Hock JM; Onyia JE
Endocrinology; 2000 Dec; 141(12):4533-42. PubMed ID: 11108265
[TBL] [Abstract][Full Text] [Related]
55. [Study of bone remodeling mechanism induced by mechanical stress. Differentiation of osteoclasts induced by compressive force in newborn rat cultured long bone].
Chiba M
Nihon Kyosei Shika Gakkai Zasshi; 1989 Dec; 48(6):585-600. PubMed ID: 2640933
[TBL] [Abstract][Full Text] [Related]
56. Regulation of the maturation of osteoblasts and osteoclastogenesis by glutamate.
Lin TH; Yang RS; Tang CH; Wu MY; Fu WM
Eur J Pharmacol; 2008 Jul; 589(1-3):37-44. PubMed ID: 18538763
[TBL] [Abstract][Full Text] [Related]
57. Synergistic effect of vitamin K2 and prostaglandin E2 on cancellous bone mass in hypophysectomized young rats.
Iwamoto J; Takeda T; Sato Y; Yeh JK
Calcif Tissue Int; 2006 Nov; 79(5):318-25. PubMed ID: 17048065
[TBL] [Abstract][Full Text] [Related]
58. Effects of acute 5-fluorouracil chemotherapy and insulin-like growth factor-I pretreatment on growth plate cartilage and metaphyseal bone in rats.
Xian CJ; Howarth GS; Cool JC; Foster BK
Bone; 2004 Sep; 35(3):739-49. PubMed ID: 15336611
[TBL] [Abstract][Full Text] [Related]
59. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone.
McCarthy TL; Centrella M; Raisz LG; Canalis E
Endocrinology; 1991 Jun; 128(6):2895-900. PubMed ID: 1645254
[TBL] [Abstract][Full Text] [Related]
60. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.
Nakayama Y; Omote K; Kawamata T; Namiki A
Brain Res; 2004 Jun; 1010(1-2):62-8. PubMed ID: 15126118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
